speb/financial-data huggingface dataset:
Financial ratios for BRY.TO — annual report dated 2022-12-31
Total revenue: 76847963.23529412
Gross profit: 15506763.235294117
Operating income: 5752578.676470588
Net income: 6355244.852941176
Capital expenditures: 1545387.5
Operating cash flow: -6297998.529411764
Depreciation & amortization: 801055.8823529411
Net tangible assets: 16475013.970588233
Owner earnings: 5610913.235294117
Return on net tangible assets (%): 34.057107601310165
Capex to operating income (%): 26.86425665625403
Buffett classification: The Good
Stock price: 0.4852941176470588
P/E ratio: 2.018454125373288
Shares outstanding: 26432981
Book value: 16475013.970588237
P/B ratio: 0.7786196851837
Market cap (USD): 12827770.19117647
Debt to equity: 1.7670636180394201
Current ratio: 1.321734150028903
Quick ratio: 0.6575187707633959
Effective tax rate (%): -87.07792585871516
Interest coverage ratio: 3.0606843157429395
COGS to revenue (%): 79.8215039378268
SG&A to revenue (%): 11.129938286282034
Free cash flow (dilution-adjusted): -7851614.705882353
Buyback yield (%): 0
Retained earnings: -9923641.176470587
Inventory turnover: 2.618130673493019
Receivables turnover: 3.3802221297800883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.627750759135658
FCF margin (%): -10.217075866854367
Rule of 40 score: -10.217075866854367
Financial ratios for BRY.TO — annual report dated 2023-12-31
Total revenue: 80329694.69696969
Gross profit: 14189272.727272727
Operating income: 3584459.848484848
Net income: 688947.7272727273
Capital expenditures: 512607.57575757575
Operating cash flow: 9612753.03030303
Depreciation & amortization: 975997.7272727272
Net tangible assets: 17077625.757575758
Owner earnings: 1152337.878787879
Return on net tangible assets (%): 6.747646863479799
Capex to operating income (%): 14.30083185265013
Buffett classification: The Great
Stock price: 0.25
P/E ratio: 9.59179483203964
Shares outstanding: 26432981
Book value: 17077625.75757575
P/B ratio: 0.3869533940962805
Market cap (USD): 6608245.25
Debt to equity: 1.4034956069136364
Current ratio: 1.4158066599522159
Quick ratio: 0.6626421385150325
Effective tax rate (%): 35.36000784711767
Interest coverage ratio: 1.2190585899486843
COGS to revenue (%): 82.33620483583391
SG&A to revenue (%): 11.755582441177529
Free cash flow (dilution-adjusted): 9090015.909090908
Buyback yield (%): 0
Retained earnings: -9535409.848484848
Inventory turnover: 3.0262292114622786
Receivables turnover: 4.251035966339442
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.736285406282141
FCF margin (%): 11.315885045227011
Revenue growth (%): 4.530675004378656
Rule of 40 score: 15.846560049605667
Financial ratios for BRY.TO — quarterly report dated 2024-09-30
Operating income: 173211.1111111111
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.2296296296296296
Shares outstanding: 26432981
Market cap (USD): 6069795.637037036
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRY.TO — annual report dated 2024-12-31
Total revenue: 58092741.95804196
Gross profit: 10072706.993006993
Operating income: -570367.8321678322
Net income: -2693305.5944055947
Capital expenditures: 289571.32867132867
Operating cash flow: 7263610.48951049
Depreciation & amortization: 893761.5384615385
Net tangible assets: 13712542.657342657
Owner earnings: -2089115.384615385
Return on net tangible assets (%): -15.235069358174256
Buffett classification: The Gruesome
Stock price: 0.2517482517482518
Shares outstanding: 26432981
Book value: 13712542.657342661
P/B ratio: 0.48528248345550207
Market cap (USD): 6654456.755244756
Debt to equity: 1.2462276382563537
Current ratio: 1.1166279097255984
Quick ratio: 0.4811159153841712
Interest coverage ratio: -0.24177936350261794
COGS to revenue (%): 82.66098887141169
SG&A to revenue (%): 14.488316192647876
Free cash flow (dilution-adjusted): 6973769.93006993
Buyback yield (%): 0
Retained earnings: -11495222.377622379
Inventory turnover: 2.8256379238596794
Receivables turnover: 4.631650755893669
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.093278199296044
FCF margin (%): 12.004545998374121
Revenue growth (%): -27.68210787158212
Rule of 40 score: -15.677561873207997
Financial ratios for BRY.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.2517482517482518
Shares outstanding: 26432981
Market cap (USD): 6654456.755244756
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRY.TO — quarterly report dated 2025-03-31
Total revenue: 13921565.034965036
Gross profit: 2406242.6573426574
Operating income: -16350.349650349652
Net income: -287958.04195804195
Capital expenditures: 26546.153846153848
Operating cash flow: 2361877.6223776224
Depreciation & amortization: 229020.97902097902
Net tangible assets: 13315683.216783218
Owner earnings: -85483.21678321678
Return on net tangible assets (%): -0.6419739444948112
Buffett classification: The Gruesome
Stock price: 0.2237762237762238
Shares outstanding: 26432981
Book value: 13315683.216783214
P/B ratio: 0.44421848845677386
Market cap (USD): 5915072.671328672
Debt to equity: 1.1428752687495536
Current ratio: 1.3632238150707936
Quick ratio: 0.6182599964718892
Interest coverage ratio: -0.03221131260306697
COGS to revenue (%): 82.71571729687574
SG&A to revenue (%): 15.030959162918645
Free cash flow (dilution-adjusted): 2335331.4685314684
Buyback yield (%): 0
Retained earnings: -11783180.41958042
Inventory turnover: 0.7764481588502603
Receivables turnover: 1.1922125394255882
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.09070063789148426
FCF margin (%): 16.774920511207693
Rule of 40 score: 16.774920511207693
Financial ratios for BRY.TO — quarterly report dated 2025-06-30
Total revenue: 14991072.99270073
Gross profit: 2846710.9489051094
Operating income: 563303.6496350365
Net income: 114435.03649635035
Capital expenditures: 129176.64233576642
Operating cash flow: 978173.7226277371
Depreciation & amortization: 215011.67883211677
Net tangible assets: 14164475.912408758
Owner earnings: 200270.07299270073
Return on net tangible assets (%): 1.4138897494771026
Capex to operating income (%): 22.931973265122597
Buffett classification: The Great
Stock price: 0.18248175182481752
P/E ratio: 10.537718225366127
Shares outstanding: 26432981
Book value: 14164475.912408758
P/B ratio: 0.3405376032731623
Market cap (USD): 4823536.678832117
Debt to equity: 1.0143251865002876
Current ratio: 1.4059457008408083
Quick ratio: 0.686323985406072
Effective tax rate (%): -67.76996586300255
Interest coverage ratio: 1.1770000854085578
COGS to revenue (%): 81.01062578848628
SG&A to revenue (%): 14.139412409429063
Free cash flow (dilution-adjusted): 848997.0802919707
Buyback yield (%): 0
Retained earnings: -12184797.08029197
Inventory turnover: 0.8428777768720809
Receivables turnover: 1.148131406111674
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.971187993555469
FCF margin (%): 5.663350986986416
Revenue growth (%): 7.682383087314861
Rule of 40 score: 13.345734074301276
Financial ratios for BRY.TO — quarterly report dated 2025-09-30
Total revenue: 13087583.45323741
Gross profit: 2617962.5899280575
Operating income: 414493.52517985617
Net income: 115297.84172661872
Capital expenditures: 153735.9712230216
Operating cash flow: 1304900.7194244605
Depreciation & amortization: 198223.74100719427
Net tangible assets: 14062717.985611511
Owner earnings: 159785.61151079138
Return on net tangible assets (%): 1.136235624395501
Capex to operating income (%): 37.09007786220854
Buffett classification: The Good
Stock price: 0.20143884892086333
P/E ratio: 11.545379311635802
Shares outstanding: 26432981
Book value: 14062717.985611513
P/B ratio: 0.3786344340855749
Market cap (USD): 5324629.266187051
Debt to equity: 0.9638355470032554
Current ratio: 1.4762834231032163
Quick ratio: 0.5964038922920336
Interest coverage ratio: 1.0100098871740213
COGS to revenue (%): 79.99659295940944
SG&A to revenue (%): 15.440638694229431
Free cash flow (dilution-adjusted): 1151164.748201439
Buyback yield (%): 0
Retained earnings: -11894178.417266188
Inventory turnover: 0.7301747660147992
Receivables turnover: 1.428294354992887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1987034142782877
FCF margin (%): 8.795854118635486
Revenue growth (%): -12.697486967011255
Rule of 40 score: -3.901632848375769
Financial ratios for BRY.TO — annual report dated 2025-12-31
Total revenue: 55183054.744525544
Gross profit: 10612311.678832116
Operating income: 1850074.4525547444
Net income: 714622.6277372262
Capital expenditures: 342736.49635036493
Operating cash flow: 8056329.927007299
Depreciation & amortization: 839389.0510948905
Net tangible assets: 14803992.700729925
Owner earnings: 1211275.1824817515
Return on net tangible assets (%): 8.182084434708134
Capex to operating income (%): 18.52555154615991
Buffett classification: The Great
Stock price: 0.16058394160583941
P/E ratio: 5.939795512510814
Shares outstanding: 26432981
Book value: 14803992.700729929
P/B ratio: 0.28672753109118815
Market cap (USD): 4244712.277372262
Debt to equity: 0.7443644370945497
Current ratio: 1.2216603775436212
Quick ratio: 0.43028307142354655
Effective tax rate (%): -380.2971953355344
Interest coverage ratio: 0.8951319776517372
COGS to revenue (%): 80.76889413251463
SG&A to revenue (%): 14.954957147601048
Free cash flow (dilution-adjusted): 7711557.6642335765
Buyback yield (%): 0
Retained earnings: -11284040.1459854
Inventory turnover: 3.3798161351427902
Receivables turnover: 8.110740171381593
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.347829298044532
FCF margin (%): 13.974503042527934
Revenue growth (%): -5.008693195473478
Rule of 40 score: 8.965809847054455
Financial ratios for BRY.TO — quarterly report dated 2025-12-31
Total revenue: 12382070.0729927
Gross profit: 2597794.1605839413
Operating income: 883292.7007299269
Net income: 783775.9124087591
Capital expenditures: 29870.80291970803
Operating cash flow: 3288888.321167883
Depreciation & amortization: 184208.75912408758
Net tangible assets: 14803992.700729925
Owner earnings: 938113.8686131387
Return on net tangible assets (%): 6.336897670632356
Capex to operating income (%): 3.3817558885094017
Buffett classification: The Great
Stock price: 0.16058394160583941
P/E ratio: 5.850331331242698
Shares outstanding: 26432981
Book value: 14803992.700729929
P/B ratio: 0.28672753109118815
Market cap (USD): 4244712.277372262
Debt to equity: 0.7443644370945497
Current ratio: 1.2216603775436212
Quick ratio: 0.43028307142354655
Effective tax rate (%): -51.59497795478577
Interest coverage ratio: 1.3757999656650017
COGS to revenue (%): 79.01971039357828
SG&A to revenue (%): 15.332300602307223
Free cash flow (dilution-adjusted): 3256981.751824817
Buyback yield (%): 0
Retained earnings: -11284040.1459854
Inventory turnover: 0.7419453059310035
Receivables turnover: 1.8199020262800272
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.895301928936364
FCF margin (%): 26.304016474020948
Revenue growth (%): -5.390707786242937
Rule of 40 score: 20.91330868777801
Financial ratios for BYN.V — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.2109375
Shares outstanding: 445671839
Market cap (USD): 94008903.5390625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYN.V — annual report dated 2022-09-30
Total revenue: 0
Operating income: -1861330.6569343065
Net income: -1062061.313868613
Capital expenditures: 13694186.861313868
Operating cash flow: -795785.401459854
Depreciation & amortization: 66770.80291970802
Net tangible assets: 27596427.007299267
Owner earnings: -14689477.372262774
Return on net tangible assets (%): -53.229635011725975
Buffett classification: The Gruesome
Stock price: 0.291970802919708
Shares outstanding: 445671839
Book value: 27596427.00729927
P/B ratio: 4.715217830087757
Market cap (USD): 130123164.67153284
Debt to equity: 0
Current ratio: 6.868765858164685
Quick ratio: 6.868765858164685
Free cash flow (dilution-adjusted): -15080076.642335767
Buyback yield (%): 0
Retained earnings: -6397175.182481752
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.478191419987901
Rule of 40 score: 0
Financial ratios for BYN.V — annual report dated 2023-09-30
Total revenue: 0
Operating income: -2139196.296296296
Net income: 272525.18518518517
Capital expenditures: 10378080
Operating cash flow: -1239142.2222222222
Depreciation & amortization: 100516.29629629629
Net tangible assets: 36266637.777777776
Owner earnings: -10005038.518518519
Return on net tangible assets (%): -27.587444360913604
Buffett classification: The Gruesome
Stock price: 0.2296296296296296
P/E ratio: 375.5229420590418
Shares outstanding: 445671839
Book value: 36266637.777777776
P/B ratio: 2.8218623395145266
Market cap (USD): 102339459.32592592
Debt to equity: 0
Current ratio: 11.144197519390652
Quick ratio: 11.144197519390652
Free cash flow (dilution-adjusted): -12144483.703703703
Buyback yield (%): 0
Retained earnings: -6219422.962962963
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.002887745562964
Rule of 40 score: 0
Financial ratios for BYN.V — quarterly report dated 2024-09-30
Capital expenditures: 3961868.148148148
Buffett classification: The Gruesome
Stock price: 0.16296296296296295
Shares outstanding: 445671839
Market cap (USD): 72628003.39259258
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYN.V — annual report dated 2024-09-30
Total revenue: 0
Operating income: -3550605.185185185
Net income: -3172257.037037037
Capital expenditures: 13152.592592592591
Operating cash flow: 433244.44444444444
Depreciation & amortization: 100594.8148148148
Net tangible assets: 42551519.259259254
Owner earnings: -3084814.814814815
Return on net tangible assets (%): -7.249599705287975
Buffett classification: The Gruesome
Stock price: 0.16296296296296295
Shares outstanding: 445671839
Book value: 42551519.259259254
P/B ratio: 1.7068251535293575
Market cap (USD): 72628003.39259258
Debt to equity: 0
Current ratio: 3.77553502249085
Quick ratio: 3.77553502249085
Free cash flow (dilution-adjusted): -844925.185185185
Buyback yield (%): 0
Retained earnings: -9391680
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.946563805773066
Rule of 40 score: 0
Financial ratios for BYN.V — quarterly report dated 2024-12-31
Capital expenditures: 2171832.167832168
Depreciation & amortization: 17693.706293706295
Buffett classification: The Gruesome
Stock price: 0.13286713286713286
Shares outstanding: 445671839
Market cap (USD): 59215139.44755245
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BYN.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -434413.98601398605
Net income: -370493.7062937063
Capital expenditures: 2140192.307692308
Operating cash flow: -1800145.4545454546
Depreciation & amortization: 19117.48251748252
Net tangible assets: 49650561.53846154
Owner earnings: -2491568.5314685316
Return on net tangible assets (%): -5.018208161731366
Buffett classification: The Gruesome
Stock price: 0.16083916083916086
Shares outstanding: 445671839
Book value: 49650561.538461536
P/B ratio: 1.4437195144082697
Market cap (USD): 71681484.5944056
Debt to equity: 0
Current ratio: 45.96384663367738
Quick ratio: 45.96384663367738
Free cash flow (dilution-adjusted): 313527.27272727276
Buyback yield (%): 0
Retained earnings: -9740473.426573427
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7385001947560487
Rule of 40 score: 0
Financial ratios for BYN.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -762516.7883211678
Net income: -642708.7591240875
Capital expenditures: 6878132.11678832
Operating cash flow: 1538494.8905109488
Depreciation & amortization: 21724.087591240874
Net tangible assets: 51684021.89781021
Owner earnings: -7499116.788321167
Return on net tangible assets (%): -14.509545722173947
Buffett classification: The Gruesome
Stock price: 0.18248175182481752
Shares outstanding: 445671839
Book value: 51684021.89781021
P/B ratio: 1.5735419755163007
Market cap (USD): 81326977.91970803
Debt to equity: 0
Current ratio: 8.09804864002835
Quick ratio: 8.09804864002835
Free cash flow (dilution-adjusted): -5788775.182481752
Buyback yield (%): 0
Retained earnings: -10809772.99270073
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2447419931414365
Rule of 40 score: 0
Financial ratios for BYN.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1241047.4820143885
Net income: 443305.75539568346
Capital expenditures: 6739312.949640288
Operating cash flow: -484030.21582733816
Depreciation & amortization: 24175.539568345324
Net tangible assets: 49720303.597122304
Owner earnings: -6271831.6546762595
Return on net tangible assets (%): -12.614226384247699
Buffett classification: The Gruesome
Stock price: 0.5035971223021583
P/E ratio: 126.57125069985963
Shares outstanding: 445671839
Book value: 49720303.597122304
P/B ratio: 4.5140322840768174
Market cap (USD): 224439055.61151078
Debt to equity: 0
Current ratio: 1.7491305193477986
Quick ratio: 1.7491305193477986
Free cash flow (dilution-adjusted): 5595479.136690647
Buyback yield (%): 0
Retained earnings: -10210930.215827338
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.101860710179473
Rule of 40 score: 0
Financial ratios for BYN.V — annual report dated 2025-09-30
Total revenue: 0
Operating income: -3210946.0431654677
Net income: -1089514.3884892086
Capital expenditures: 72403.59712230216
Operating cash flow: -1257354.6762589929
Depreciation & amortization: 83457.55395683454
Net tangible assets: 49720303.597122304
Owner earnings: -1078460.4316546763
Return on net tangible assets (%): -2.1690543975622365
Buffett classification: The Gruesome
Stock price: 0.5035971223021583
Shares outstanding: 445671839
Book value: 49720303.597122304
P/B ratio: 4.5140322840768174
Market cap (USD): 224439055.61151078
Debt to equity: 0
Current ratio: 1.7491305193477986
Quick ratio: 1.7491305193477986
Free cash flow (dilution-adjusted): -2646801.438848921
Buyback yield (%): 0
Retained earnings: -10210930.215827338
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.438116936252317
Rule of 40 score: 0
Financial ratios for BYN.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -1625295.6204379562
Net income: -1378001.4598540145
Capital expenditures: 7033855.474452554
Operating cash flow: -1265871.5328467153
Depreciation & amortization: 18693.430656934306
Net tangible assets: 67777838.68613139
Owner earnings: -8393163.503649633
Return on net tangible assets (%): -12.383344860725149
Buffett classification: The Gruesome
Stock price: 0.6642335766423357
Shares outstanding: 445671839
Book value: 67777838.68613139
P/B ratio: 4.3676547580486735
Market cap (USD): 296030199.6277372
Debt to equity: 0
Current ratio: 3.519746792100205
Quick ratio: 3.519746792100205
Free cash flow (dilution-adjusted): -8629102.919708028
Buyback yield (%): 0
Retained earnings: -11737996.350364963
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1042463599024814
Rule of 40 score: 0
Financial ratios for CHR.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18
Shares outstanding: 22982146
Market cap (USD): 413678628
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHR.TO — annual report dated 2022-12-31
Total revenue: 1173385294.117647
Gross profit: 311321323.52941173
Operating income: 138430882.35294116
Net income: 38174264.70588235
Capital expenditures: 153696323.52941176
Operating cash flow: 205523529.41176468
Depreciation & amortization: 148980147.05882353
Net tangible assets: 846825735.2941176
Owner earnings: 33458088.235294104
Return on net tangible assets (%): 3.9510004054935246
Capex to operating income (%): 111.02748239193483
Buffett classification: The Gruesome
Stock price: 16.40441176470588
P/E ratio: 9.875988159177147
Shares outstanding: 22982146
Book value: 932663970.5882354
P/B ratio: 0.404227672677017
Market cap (USD): 377008586.2205882
Debt to equity: 1.6006300737214634
Current ratio: 0.6875331825644987
Quick ratio: 0.532187599377089
Effective tax rate (%): 29.69939065673663
Interest coverage ratio: 1.7948898846410524
COGS to revenue (%): 73.46810761221303
Free cash flow (dilution-adjusted): 159729411.76470587
Buyback yield (%): 1.0654695705937003
Retained earnings: -516479411.76470584
Inventory turnover: 10.30053593393077
Receivables turnover: 7.830091656689761
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.665168120076312
FCF margin (%): 13.612699303924542
Rule of 40 score: 13.612699303924542
Financial ratios for CHR.TO — annual report dated 2023-12-31
Total revenue: 1060311363.6363636
Gross profit: 255399242.4242424
Operating income: 120098484.84848484
Net income: 80383333.33333333
Capital expenditures: 32025757.575757574
Operating cash flow: 227026515.15151513
Depreciation & amortization: 69302272.72727272
Net tangible assets: 886604545.4545454
Owner earnings: 117659848.48484848
Return on net tangible assets (%): 13.270837498867829
Capex to operating income (%): 26.666246136377975
Buffett classification: The Good
Stock price: 13.348484848484848
P/E ratio: 3.81642331743728
Shares outstanding: 22982146
Book value: 970052272.7272725
P/B ratio: 0.31624772838702075
Market cap (USD): 306776827.6666666
Debt to equity: 1.371044515720412
Current ratio: 0.7838371814163746
Quick ratio: 0.5272020805866996
Effective tax rate (%): 25.841335629432887
Interest coverage ratio: 3.7008590904846392
COGS to revenue (%): 75.91280720142953
Free cash flow (dilution-adjusted): 194990909.0909091
Buyback yield (%): 6.3060351372023
Retained earnings: -491956060.60606056
Inventory turnover: 5.144378864394551
Receivables turnover: 6.049860382284543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.204369924237401
FCF margin (%): 18.389966926524583
Revenue growth (%): -9.636555958911327
Rule of 40 score: 8.753410967613256
Financial ratios for CHR.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.533333333333333
Shares outstanding: 22982146
Market cap (USD): 334007188.5333333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHR.TO — quarterly report dated 2024-12-31
Total revenue: 246961538.46153846
Gross profit: 39232167.832167834
Operating income: 9303496.503496503
Net income: -4612587.412587413
Capital expenditures: 8923076.923076924
Operating cash flow: 22149650.34965035
Depreciation & amortization: 26353846.153846156
Net tangible assets: 351830069.9300699
Owner earnings: 12818181.81818182
Capex to operating income (%): 95.91100420926038
Buffett classification: The Gruesome
Stock price: 14.972027972027973
Shares outstanding: 22982146
Book value: 358005594.40559435
P/B ratio: 0.9611283682327114
Market cap (USD): 344089332.7692308
Debt to equity: 1.0086551759163043
Current ratio: 0.946242714860197
Quick ratio: 0.6859332244392039
Interest coverage ratio: 0.5803777865026393
COGS to revenue (%): 84.11405756679079
Free cash flow (dilution-adjusted): 13226573.426573427
Buyback yield (%): 106.96990371941627
Retained earnings: -585311888.1118882
Inventory turnover: 1.9978276659851502
Receivables turnover: 2.4850819787488563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2842913711914836
FCF margin (%): 5.355721991759992
Rule of 40 score: 5.355721991759992
Financial ratios for CHR.TO — annual report dated 2024-12-31
Total revenue: 982485314.6853148
Gross profit: 189435664.33566433
Operating income: 64787412.58741259
Net income: -109404895.10489511
Capital expenditures: 36919580.41958042
Operating cash flow: 185325874.12587413
Depreciation & amortization: 81392307.6923077
Net tangible assets: 351830069.9300699
Owner earnings: -64932167.83216784
Return on net tangible assets (%): -18.455548113063166
Capex to operating income (%): 56.985730630572284
Buffett classification: The Good
Stock price: 14.972027972027973
Shares outstanding: 22982146
Book value: 358005594.40559435
P/B ratio: 0.9611283682327114
Market cap (USD): 344089332.7692308
Debt to equity: 1.0086551759163043
Current ratio: 0.946242714860197
Quick ratio: 0.6859332244392039
Interest coverage ratio: 1.790053327150475
COGS to revenue (%): 80.71872815764786
Free cash flow (dilution-adjusted): 148339160.83916086
Buyback yield (%): 107.98565880457869
Retained earnings: -585311888.1118882
Inventory turnover: 7.627118530076402
Receivables turnover: 9.886383787207095
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.94351010037629
FCF margin (%): 15.098359092183802
Revenue growth (%): -7.339924065714294
Rule of 40 score: 7.758435026469508
Financial ratios for CHR.TO — quarterly report dated 2025-03-31
Total revenue: 243446853.14685315
Gross profit: 50006293.70629371
Operating income: 20776223.77622378
Net income: 13239860.13986014
Capital expenditures: 4292307.692307693
Operating cash flow: -15744055.944055945
Depreciation & amortization: 18986713.286713287
Net tangible assets: 354820279.72027975
Owner earnings: 27934265.734265734
Return on net tangible assets (%): 7.872792884411097
Capex to operating income (%): 20.659710535173343
Buffett classification: The Great
Stock price: 13.027972027972028
P/E ratio: 5.653586066392013
Shares outstanding: 22982146
Book value: 360995804.19580424
P/B ratio: 0.8294023136855317
Market cap (USD): 299410755.2307692
Debt to equity: 0.8105725421522438
Current ratio: 1.2206249136268812
Quick ratio: 0.7104838868890542
Effective tax rate (%): 27.5125387648838
Interest coverage ratio: 5.462401176686892
COGS to revenue (%): 79.45905109887427
Free cash flow (dilution-adjusted): -20211888.111888114
Buyback yield (%): 3.096992045452866
Retained earnings: -574700699.3006994
Inventory turnover: 1.7841962344958366
Receivables turnover: 2.9048028302988835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.6695371753942534
FCF margin (%): -8.302382162933856
Revenue growth (%): -1.423171128824454
Rule of 40 score: -9.72555329175831
Financial ratios for CHR.TO — quarterly report dated 2025-06-30
Total revenue: 236943065.69343063
Gross profit: 47834306.56934306
Operating income: 17570802.91970803
Net income: 23676642.33576642
Capital expenditures: 5015328.467153285
Operating cash flow: 16663503.649635036
Depreciation & amortization: 19895620.437956203
Net tangible assets: 385689051.0948905
Owner earnings: 38556934.30656934
Return on net tangible assets (%): 9.996896255445746
Capex to operating income (%): 28.543536058491192
Buffett classification: The Good
Stock price: 16.043795620437955
P/E ratio: 11.414122796680498
Shares outstanding: 22982146
Book value: 392135036.4963503
P/B ratio: 0.9402905097119457
Market cap (USD): 368720853.3430657
Debt to equity: 0.7152999208897576
Current ratio: 1.1430962896450434
Quick ratio: 0.6118692379172452
Effective tax rate (%): 1.2061036152651297
Interest coverage ratio: 5.537612146307799
COGS to revenue (%): 79.81189851268591
Free cash flow (dilution-adjusted): 11462043.795620438
Buyback yield (%): 2.8415458924492545
Retained earnings: -574551094.8905109
Inventory turnover: 1.697342732478151
Receivables turnover: 3.2773531757650405
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2579876594858557
FCF margin (%): 4.837467499661134
Revenue growth (%): -2.671543036746206
Rule of 40 score: 2.165924462914928
Financial ratios for CHR.TO — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.978417266187051
P/E ratio: 11.367610326606767
Shares outstanding: 22982146
Market cap (USD): 367218318.4604317
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHR.TO — annual report dated 2025-12-31
Total revenue: 960947445.2554743
Gross profit: 193330656.93430656
Operating income: 72704379.56204379
Net income: 57473722.627737224
Capital expenditures: 19705109.489051092
Operating cash flow: 45800729.927007295
Depreciation & amortization: 78305109.48905109
Net tangible assets: 361886861.3138686
Owner earnings: 116073722.62773724
Return on net tangible assets (%): 32.07458878344444
Capex to operating income (%): 27.103057075448017
Buffett classification: The Good
Stock price: 15.510948905109489
P/E ratio: 6.202397826998057
Shares outstanding: 22982146
Book value: 370683941.6058394
P/B ratio: 0.961668020447506
Market cap (USD): 356474892.33576643
Debt to equity: 0.7367639616648649
Current ratio: 1.3011112055575733
Quick ratio: 0.6859917007317884
Effective tax rate (%): 20.175385239253853
Interest coverage ratio: 5.654234786557674
COGS to revenue (%): 79.8812455468979
Free cash flow (dilution-adjusted): 20332116.788321167
Buyback yield (%): 17.568625048433375
Retained earnings: -555475912.4087591
Inventory turnover: 6.60558151805231
Receivables turnover: 10.706978862529176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.471505132993796
FCF margin (%): 2.1158406621202617
Revenue growth (%): -2.192182326586624
Rule of 40 score: -0.07634166446636215
Financial ratios for CHR.TO — quarterly report dated 2025-12-31
Total revenue: 233715328.46715328
Gross profit: 44748175.18248175
Operating income: 15310948.905109487
Net income: 12191970.802919706
Capital expenditures: 1310948.9051094889
Operating cash flow: 16943795.620437954
Depreciation & amortization: 19086131.386861313
Net tangible assets: 361886861.3138686
Owner earnings: 29967153.28467153
Return on net tangible assets (%): 8.280807204735924
Capex to operating income (%): 8.562166285278414
Buffett classification: The Great
Stock price: 15.510948905109489
P/E ratio: 7.258928419823174
Shares outstanding: 22982146
Book value: 370683941.6058394
P/B ratio: 0.961668020447506
Market cap (USD): 356474892.33576643
Debt to equity: 0.7367639616648649
Current ratio: 1.3011112055575733
Quick ratio: 0.6859917007317884
Effective tax rate (%): 28.01982331394096
Interest coverage ratio: 5.422957600827301
COGS to revenue (%): 80.85355570130235
Free cash flow (dilution-adjusted): 10418978.10218978
Buyback yield (%): 10.293617130650281
Retained earnings: -555475912.4087591
Inventory turnover: 1.6261212029848495
Receivables turnover: 2.604081101523297
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.994621672302373
FCF margin (%): 4.457978075517661
Rule of 40 score: 4.457978075517661
Financial ratios for CHRY.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.03608108108108108
Shares outstanding: 480973805
Market cap (USD): 17354054.85608108
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRY.L — annual report dated 2022-09-30
Total revenue: -664547777.7777778
Net income: -668102222.2222222
Capital expenditures: 0
Operating cash flow: -39103333.333333336
Net tangible assets: 977313333.3333333
Owner earnings: -668102222.2222222
Return on net tangible assets (%): -68.36110788988407
Buffett classification: The Gruesome
Stock price: 0.006888888888888889
Shares outstanding: 480973805
Book value: 977313333.3333333
P/B ratio: 0.0033902894681792036
Market cap (USD): 3313375.101111111
Debt to equity: 0
Free cash flow (dilution-adjusted): -39103333.333333336
Buyback yield (%): 0
Receivables turnover: -157.76655236085466
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRY.L — annual report dated 2023-09-30
Total revenue: -92160975.6097561
Net income: -95406097.56097561
Capital expenditures: 0
Operating cash flow: -44042682.92682927
Net tangible assets: 977254878.0487806
Owner earnings: -95406097.56097561
Return on net tangible assets (%): -9.762662710005253
Buffett classification: The Gruesome
Stock price: 0.007560975609756097
Shares outstanding: 480973805
Book value: 977254878.0487806
P/B ratio: 0.0037212719938503696
Market cap (USD): 3636631.2085365853
Debt to equity: 0
Free cash flow (dilution-adjusted): -44042682.92682927
Buyback yield (%): 0
Receivables turnover: -1511.44
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRY.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1120441333.3333333
Buffett classification: The Gruesome
Stock price: 0.012400000000000001
Shares outstanding: 480973805
Book value: 1120441333.3333333
P/B ratio: 0.0053229696232794
Market cap (USD): 5964075.182000001
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRY.L — annual report dated 2024-09-30
Total revenue: 56598666.666666664
Net income: 52292000
Capital expenditures: 0
Operating cash flow: 30913333.333333332
Net tangible assets: 1120441333.3333333
Owner earnings: 52292000
Return on net tangible assets (%): 4.667089515916943
Buffett classification: The Gruesome
Stock price: 0.012400000000000001
P/E ratio: 0.11405330035187028
Shares outstanding: 480973805
Book value: 1120441333.3333333
P/B ratio: 0.0053229696232794
Market cap (USD): 5964075.182000001
Debt to equity: 0
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 7.609130957148579
Free cash flow (dilution-adjusted): 30913333.333333332
Buyback yield (%): 0
Receivables turnover: 30.84956395348837
Capitalized R&D asset: 0
FCF margin (%): 54.61848335649838
Rule of 40 score: 54.61848335649838
Financial ratios for CHRY.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 1074666233.7662337
Buffett classification: The Gruesome
Stock price: 0.011948051948051947
Shares outstanding: 480973805
Book value: 1074666233.7662337
P/B ratio: 0.005347427719630257
Market cap (USD): 5746700.007792207
Debt to equity: 0.08521038848666998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHRY.L — annual report dated 2025-09-30
Total revenue: 167005405.4054054
Net income: 162795945.94594595
Capital expenditures: 0
Operating cash flow: 132309459.45945945
Net tangible assets: 1181852702.7027028
Owner earnings: 162795945.94594595
Return on net tangible assets (%): 13.774639223116248
Buffett classification: The Gruesome
Stock price: 0.01635135135135135
P/E ratio: 0.048309382832927975
Shares outstanding: 480973805
Book value: 1181852702.7027028
P/B ratio: 0.006654443196149883
Market cap (USD): 7864571.676351351
Debt to equity: 0.08110033376363954
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 2.5205528223718283
Free cash flow (dilution-adjusted): 132309459.45945945
Buyback yield (%): 1475.3299118281798
Receivables turnover: 13.126287838555497
Capitalized R&D asset: 0
FCF margin (%): 79.22465691351631
Revenue growth (%): 195.0695047093078
Rule of 40 score: 274.2941616228241
Financial ratios for CHRY.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 1181852702.7027028
Buffett classification: The Gruesome
Stock price: 0.01635135135135135
Shares outstanding: 480973805
Book value: 1181852702.7027028
P/B ratio: 0.006654443196149883
Market cap (USD): 7864571.676351351
Debt to equity: 0.08110033376363954
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMRE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.9
Shares outstanding: 120738359
Market cap (USD): 1316048113.1000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMRE — annual report dated 2022-12-31
Total revenue: 1184956382.9787235
Gross profit: 638996808.5106384
Operating income: 568503191.4893618
Net income: 590377659.5744681
Capital expenditures: 168535106.38297874
Operating cash flow: 618715957.4468086
Depreciation & amortization: 176804255.31914896
Net tangible assets: 2294129787.2340426
Owner earnings: 598646808.5106385
Return on net tangible assets (%): 26.09472279388375
Capex to operating income (%): 29.64541077446748
Buffett classification: The Good
Stock price: 8.42
P/E ratio: 1.721977392424971
Shares outstanding: 120738359
Book value: 2298337234.042553
P/B ratio: 0.4423271605759391
Market cap (USD): 1016616982.78
Debt to equity: 1.196341758634943
Current ratio: 2.3981233307334135
Quick ratio: 2.33185137913919
Interest coverage ratio: 4.984776829438926
COGS to revenue (%): 46.074233812358656
SG&A to revenue (%): 1.7532739781247
Free cash flow (dilution-adjusted): 545328723.4042554
Buyback yield (%): 6.288587751997518
Retained earnings: 794317021.2765958
Inventory turnover: 18.303149185063663
Receivables turnover: 23.66086753335033
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.946711246844778
FCF margin (%): 46.02099547608809
Rule of 40 score: 46.02099547608809
Financial ratios for CMRE — annual report dated 2023-12-31
Total revenue: 942543333.3333333
Gross profit: 578874444.4444444
Operating income: 528092222.2222222
Net income: 428610000
Capital expenditures: 30621111.111111112
Operating cash flow: 368186666.6666667
Depreciation & amortization: 140798888.8888889
Net tangible assets: 2646957777.7777777
Owner earnings: 538787777.7777777
Return on net tangible assets (%): 20.354981945730565
Capex to operating income (%): 5.798440087274319
Buffett classification: The Great
Stock price: 9.78
P/E ratio: 2.755001402253797
Shares outstanding: 120738359
Book value: 2710432222.222222
P/B ratio: 0.43565787823016344
Market cap (USD): 1180821151.02
Debt to equity: 1.0854509059440707
Current ratio: 1.6863482052597434
Quick ratio: 1.5939088975059224
Interest coverage ratio: 3.7485842732076664
COGS to revenue (%): 38.5837845356948
SG&A to revenue (%): 2.148324450747328
Free cash flow (dilution-adjusted): 132282222.22222221
Buyback yield (%): 5.645788662328721
Retained earnings: 1162146666.6666667
Inventory turnover: 5.342310580093364
Receivables turnover: 10.21874887065881
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.278051455673264
FCF margin (%): 14.034603773006605
Revenue growth (%): -20.45755043202657
Rule of 40 score: -6.4229466590199635
Financial ratios for CMRE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.08
Shares outstanding: 120738359
Market cap (USD): 1820734453.72
Buyback yield (%): 6.9784415091004
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMRE — quarterly report dated 2024-12-31
Capital expenditures: 109186458.33333334
Operating cash flow: 134307291.6666667
Depreciation & amortization: 43161458.333333336
Buffett classification: The Gruesome
Stock price: 12.4
Shares outstanding: 120738359
Market cap (USD): 1497155651.6000001
Free cash flow (dilution-adjusted): 25120833.333333343
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMRE — annual report dated 2024-12-31
Total revenue: 925512500
Gross profit: 571328125
Operating income: 515786458.3333334
Net income: 333248958.3333334
Capital expenditures: 43578125
Operating cash flow: 560120833.3333334
Depreciation & amortization: 132105208.33333334
Net tangible assets: 2618166666.666667
Owner earnings: 421776041.66666675
Return on net tangible assets (%): 16.10959481825705
Capex to operating income (%): 8.448869545899768
Buffett classification: The Great
Stock price: 12.4
P/E ratio: 4.492604145224259
Shares outstanding: 120738359
Book value: 2675631250
P/B ratio: 0.5595523118516424
Market cap (USD): 1497155651.6000001
Debt to equity: 0.6702923687011555
Current ratio: 1.3952143355330224
Quick ratio: 1.377568539084715
Interest coverage ratio: 4.229491253245866
COGS to revenue (%): 38.26899960832512
SG&A to revenue (%): 2.7776277107728604
Free cash flow (dilution-adjusted): 439237500
Buyback yield (%): 7.95626748668604
Retained earnings: 1332921875
Inventory turnover: 25.8450136819702
Receivables turnover: 34.3963454763656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.245530733044948
FCF margin (%): 47.4588403722262
Revenue growth (%): -1.806901893104818
Rule of 40 score: 45.651938479121384
Financial ratios for CMRE — quarterly report dated 2025-03-31
Total revenue: 242244565.21739128
Gross profit: 147483695.6521739
Operating income: 133658695.6521739
Net income: 109611956.52173913
Capital expenditures: 3116304.347826087
Operating cash flow: 160011956.52173913
Depreciation & amortization: 34352173.91304348
Net tangible assets: 2814986956.521739
Owner earnings: 140847826.0869565
Return on net tangible assets (%): 5.003498355849977
Capex to operating income (%): 2.331538799342908
Buffett classification: The Great
Stock price: 9.57
P/E ratio: 2.635355969129241
Shares outstanding: 120738359
Book value: 2874446739.1304345
P/B ratio: 0.4019786068395015
Market cap (USD): 1155466095.63
Debt to equity: 0.8614156750769808
Current ratio: 1.5484631058491787
Quick ratio: 1.471125207105816
Interest coverage ratio: 5.216170357173157
COGS to revenue (%): 39.11785161420591
SG&A to revenue (%): 2.546833284723936
Free cash flow (dilution-adjusted): 153343478.26086956
Buyback yield (%): 0
Retained earnings: 1479030434.7826087
Inventory turnover: 1.5551195148055657
Receivables turnover: 3.179879005792883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.79281634381035
FCF margin (%): 63.301101563726924
Rule of 40 score: 63.301101563726924
Financial ratios for CMRE — quarterly report dated 2025-06-30
Total revenue: -6430588.235294118
Gross profit: 146231764.70588237
Operating income: 144520000
Net income: 105477647.05882353
Capital expenditures: 129097647.05882353
Operating cash flow: 173552941.1764706
Depreciation & amortization: 25704705.88235294
Net tangible assets: 2291812941.1764708
Owner earnings: 2084705.8823529482
Return on net tangible assets (%): 0.09096317787972666
Capex to operating income (%): 89.32856840494293
Buffett classification: The Gruesome
Stock price: 8.94
P/E ratio: 5.018377975929023
Shares outstanding: 120738359
Book value: 2375435294.117647
P/B ratio: 0.45440131841643877
Market cap (USD): 1079400929.46
Debt to equity: 0.7868521930345893
Current ratio: 1.6764902662394126
Quick ratio: 1.6382107324631143
Interest coverage ratio: 5.51950035945363
Free cash flow (dilution-adjusted): 7555294.117647059
Buyback yield (%): 0
Retained earnings: 860141176.4705882
Inventory turnover: 6.666784602320973
Receivables turnover: -0.1892855906084427
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.645247575463171
Revenue growth (%): -102.65458514188886
Rule of 40 score: -102.65458514188886
Financial ratios for CMRE — quarterly report dated 2025-09-30
Total revenue: 264903529.4117647
Gross profit: 152241176.47058824
Operating income: 138950588.23529413
Net income: 116883529.41176471
Capital expenditures: 74725882.35294119
Operating cash flow: 159554117.6470588
Depreciation & amortization: 38434117.64705882
Net tangible assets: 2383328235.294118
Owner earnings: 80591764.70588234
Return on net tangible assets (%): 3.3814798781140945
Capex to operating income (%): 53.778744877569686
Buffett classification: The Good
Stock price: 11.83
P/E ratio: 4.302561397349622
Shares outstanding: 120738359
Book value: 2468210588.2352934
P/B ratio: 0.5786924315851114
Market cap (USD): 1428334786.97
Debt to equity: 0.7541877206587867
Current ratio: 1.6824274834311204
Quick ratio: 1.645176333430487
Interest coverage ratio: 5.370742576508572
COGS to revenue (%): 42.529577915156686
SG&A to revenue (%): 1.7582427343139344
Free cash flow (dilution-adjusted): 34301176.47058824
Buyback yield (%): 0
Retained earnings: 952903529.4117647
Inventory turnover: 6.515376241665534
Receivables turnover: 8.501717953558618
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.407221666731095
FCF margin (%): 12.948553968592341
Rule of 40 score: 12.948553968592341
Financial ratios for CMRE — annual report dated 2025-12-31
Total revenue: 1032823529.4117647
Gross profit: 591568235.2941177
Operating income: 534024705.88235295
Net income: 434117647.0588235
Capital expenditures: 210703529.4117647
Operating cash flow: 640322352.9411765
Depreciation & amortization: 152550588.23529413
Net tangible assets: 2454345882.352941
Owner earnings: 375964705.88235295
Return on net tangible assets (%): 15.31832610006548
Capex to operating income (%): 39.45576432903523
Buffett classification: The Good
Stock price: 15.69
P/E ratio: 4.363759145808943
Shares outstanding: 120738359
Book value: 2539948235.294118
P/B ratio: 0.7458360081462984
Market cap (USD): 1894384852.71
Debt to equity: 0.7016530211824603
Current ratio: 1.732873687802332
Quick ratio: 1.697444350775777
Interest coverage ratio: 5.060886143691745
COGS to revenue (%): 42.72320309830276
SG&A to revenue (%): 2.2775942590272242
Free cash flow (dilution-adjusted): 276681176.47058827
Buyback yield (%): 0
Retained earnings: 1022038823.5294118
Inventory turnover: 26.560937610650804
Receivables turnover: 36.335416580439556
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.103599382695736
FCF margin (%): 26.788814215742114
Revenue growth (%): 11.594768240489971
Rule of 40 score: 38.383582456232084
Financial ratios for CMRE — quarterly report dated 2025-12-31
Total revenue: 249378823.52941176
Gross profit: 134191764.70588236
Operating income: 118471764.70588236
Net income: 93117647.05882353
Capital expenditures: 8908235.294117648
Operating cash flow: 138883529.4117647
Depreciation & amortization: 39381176.47058824
Net tangible assets: 2454345882.352941
Owner earnings: 123590588.23529412
Return on net tangible assets (%): 5.035581542272674
Capex to operating income (%): 7.519289778651653
Buffett classification: The Great
Stock price: 15.69
P/E ratio: 4.456424231271377
Shares outstanding: 120738359
Book value: 2539948235.294118
P/B ratio: 0.7458360081462984
Market cap (USD): 1894384852.71
Debt to equity: 0.7016530211824603
Current ratio: 1.732873687802332
Quick ratio: 1.697444350775777
Interest coverage ratio: 4.667269187986651
COGS to revenue (%): 46.18959107806691
SG&A to revenue (%): 2.8121638706999037
Free cash flow (dilution-adjusted): 75055294.11764707
Buyback yield (%): 0
Retained earnings: 1022038823.5294118
Inventory turnover: 6.933574109482331
Receivables turnover: 8.773312362898887
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9069938633304986
FCF margin (%): 30.096899590511956
Revenue growth (%): -5.86051303915299
Rule of 40 score: 24.236386551358965
Financial ratios for CQR.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.05511811023622048
Shares outstanding: 154777106
Market cap (USD): 8531021.590551183
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CQR.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -630505.8823529411
Net income: -619258.0882352941
Capital expenditures: 0
Operating cash flow: -559407.3529411764
Net tangible assets: 849946.3235294117
Owner earnings: -619258.0882352941
Return on net tangible assets (%): -72.85849365920166
Buffett classification: The Gruesome
Stock price: 0.014705882352941176
Shares outstanding: 154777106
Book value: 849946.3235294117
P/B ratio: 2.6779737128728716
Market cap (USD): 2276133.911764706
Debt to equity: 0
Current ratio: 18.449535052231145
Quick ratio: 18.449535052231145
Free cash flow (dilution-adjusted): -736262.4999999999
Buyback yield (%): 0
Retained earnings: -17541636.76470588
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -74.18184712356403
Rule of 40 score: 0
Financial ratios for CQR.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: 204693.1818181818
Net income: 330771.96969696967
Capital expenditures: 0
Operating cash flow: -130580.30303030302
Net tangible assets: 1227745.4545454546
Owner earnings: 330771.96969696967
Return on net tangible assets (%): 26.941412690420474
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.015151515151515152
P/E ratio: 7.089801680641476
Shares outstanding: 154777106
Book value: 1227745.4545454544
P/B ratio: 1.910092729713987
Market cap (USD): 2345107.6666666665
Debt to equity: 0
Current ratio: 31.18557214963754
Quick ratio: 31.18557214963754
Free cash flow (dilution-adjusted): -144275.75757575757
Buyback yield (%): 0
Retained earnings: -17742429.545454543
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.67228178775583
Rule of 40 score: 0
Financial ratios for CQR.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.02222222222222222
Shares outstanding: 154777106
Market cap (USD): 3439491.244444444
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0